| 9th Nov 2023 3:00 pm |
RNS |
Director Declaration |
| 9th Nov 2023 7:10 am |
RNS |
Imfinzi combination improves PFS in liver cancer |
| 9th Nov 2023 7:05 am |
RNS |
Agreement with Eccogene for clinical stage GLP-1RA |
| 9th Nov 2023 7:00 am |
RNS |
9M and Q3 2023 results |
| 1st Nov 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2023 7:00 am |
RNS |
AstraZeneca cell & gene therapy deal w/ Cellectis |
| 3rd Oct 2023 7:00 am |
RNS |
AstraZeneca settles Nexium liability litigations |
| 2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Sep 2023 7:00 am |
RNS |
Dato-DXd improved PFS in breast cancer |
| 20th Sep 2023 7:00 am |
RNS |
Alexion completes Pfizer gene therapy agreement |
| 15th Sep 2023 3:00 pm |
RNS |
Enhertu recommended in EU for HER2-mutant NSCLC |
| 11th Sep 2023 4:00 pm |
RNS |
Fasenra Phase III EGPA trial met primary endpoint |
| 6th Sep 2023 7:00 am |
RNS |
Update on US review of Ultomiris for NMOSD |
| 1st Sep 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Aug 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Jul 2023 7:05 am |
RNS |
Alexion enters gene therapy agreement with Pfizer |
| 28th Jul 2023 7:00 am |
RNS |
Half-year Report |
| 17th Jul 2023 6:10 pm |
RNS |
Beyfortus approved in US for infant RSV prevention |
| 3rd Jul 2023 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Jul 2023 7:00 am |
RNS |
Dato-DXd significantly improved PFS in lung cancer |
| 9th Jun 2023 7:05 am |
RNS |
nirsevimab recommended for infant RSV protection |
| 9th Jun 2023 7:00 am |
RNS |
AstraZeneca agreement with Quell Therapeutics |
| 2nd Jun 2023 5:00 pm |
RNS |
Imfinzi improved pCR in gastric and GEJ cancers |
| 1st Jun 2023 3:05 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jun 2023 7:00 am |
RNS |
Lynparza approved in US for BRCAm prostate cancer |
| 26th May 2023 7:00 am |
RNS |
Imfinzi + Lynparza prolonged PFS in endometrial ca |
| 22nd May 2023 7:05 am |
RNS |
Directorate Change |
| 17th May 2023 7:00 am |
RNS |
Tagrisso plus chemo improved PFS in lung cancer |
| 9th May 2023 11:00 am |
RNS |
Director/PDMR Shareholding |
| 9th May 2023 7:00 am |
RNS |
Farxiga extended in the US for heart failure |
| 2nd May 2023 3:00 pm |
RNS |
Total Voting Rights |
| 2nd May 2023 10:00 am |
RNS |
Director/PDMR Shareholding |
| 2nd May 2023 7:00 am |
RNS |
ODAC vote on Lynparza combo in prostate cancer |
| 27th Apr 2023 5:30 pm |
RNS |
Result of AGM |
| 27th Apr 2023 7:05 am |
RNS |
Board Committee Changes |
| 27th Apr 2023 7:00 am |
RNS |
1st Quarter Results |
| 26th Apr 2023 4:45 pm |
RNS |
Director Declaration |
| 11th Apr 2023 7:00 am |
RNS |
Update to arrangements with Sobi and Sanofi |
| 5th Apr 2023 7:00 am |
RNS |
Lynparza + Imfinzi met endpoint in ovarian cancer |
